Starpharma Holdings Ltd. (OTCMKTS:SPHRY – Get Free Report)’s share price fell 4.2% on Friday . The company traded as low as $2.10 and last traded at $2.30. 250 shares traded hands during trading, a decline of 89% from the average session volume of 2,278 shares. The stock had previously closed at $2.40.
Starpharma Trading Down 4.2%
The firm has a 50 day moving average of $1.61 and a 200 day moving average of $0.98. The company has a quick ratio of 3.95, a current ratio of 4.32 and a debt-to-equity ratio of 0.06.
Starpharma Company Profile
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.
Featured Articles
- Five stocks we like better than Starpharma
- Election Stocks: How Elections Affect the Stock Market
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- What is the FTSE 100 index?
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}
